Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Oct 19;3(4):606-610.
doi: 10.1016/j.jaccao.2021.06.001. eCollection 2021 Oct.

Amyloid Cardiomyopathy: Establishing a Patient Referral Center in Brazil

Roberta Shcolnik Szor  1   2 , Aristoteles Alencar  3 , Bruno Vaz Kerges Bueno  3 , Caio Rebouças Fonseca Cafezeiro  3 , Lucas Bassolli de Oliveira Alves  1 , Ludhmila Abrahão Hajjar  3 , Gracia Aparecida Martinez  1   2 , Vanderson Rocha  1   2   4 , Fabio Fernandes  3
Affiliations
Editorial

Amyloid Cardiomyopathy: Establishing a Patient Referral Center in Brazil

Roberta Shcolnik Szor et al. JACC CardioOncol. .
No abstract available

Keywords: AL amyloidosis; ATTR amyloidosis; amyloid cardiomyopathy; systemic amyloidosis.

PubMed Disclaimer

Conflict of interest statement

Dr Szor has received lecture honoraria from Alnylam, Pfizer, and Janssen-Cilag Pharmaceuticals; and has reported membership on the advisory board of Janssen-Cilag Pharmaceuticals. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

Figure 1
Figure 1
Imaging, Biomarkers, and Survival in Amyloid Cardiomyopathy (A) Imaging and biomarker parameters by amyloidosis subtypes. (B) Overall survival in AL (light chain) and ATTR (transthyretin amyloid) cardiomyopathy.
See this image and copyright information in PMC

References

    1. Gertz M.A., Dispenzieri A. Systemic amyloidosis recognition, prognosis, and therapy: a systematic review. JAMA. 2020;324(1):79–89. - PubMed
    1. Muchtar E., Dispenzieri A., Magen H. Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med. 2021;289(3):268–292. - PubMed
    1. Ruberg F.L., Grogan M., Hanna M., Kelly J.W., Maurer M.S. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(22):2872–2891. - PMC - PubMed
    1. Palladini G., Milani P., Merlini G. Management of AL amyloidosis in 2020. Blood. 2020;136(23):2620–2627. - PubMed
    1. Castiglione V., Franzini M., Aimo A. Use of biomarkers to diagnose and manage cardiac amyloidosis. Eur J Heart Fail. 2021;23(2):217–230. - PubMed

Publication types